These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24182544)

  • 1. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia: a Cochrane review summary.
    Roberts H; Hickey M; Lethaby A
    Maturitas; 2014 Jan; 77(1):4-6. PubMed ID: 24182544
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
    Furness S; Roberts H; Marjoribanks J; Lethaby A; Hickey M; Farquhar C
    Cochrane Database Syst Rev; 2009 Apr; (2):CD000402. PubMed ID: 19370558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
    Furness S; Roberts H; Marjoribanks J; Lethaby A
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD000402. PubMed ID: 22895916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy: estrogen after menopause.
    Gibaldi M
    Pharmacotherapy; 1996; 16(3):366-75. PubMed ID: 8726594
    [No Abstract]   [Full Text] [Related]  

  • 5. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ultrasonic evaluation of endometrial changes induced by cyclic sequential hormone substitution therapy].
    Berardesca C; Chiechi LM; Caradonna F; Loizzi V; Loizzi P
    Minerva Ginecol; 1998 Dec; 50(12):503-5. PubMed ID: 10069161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone replacement therapy of menopause in women with vascular risk factors].
    Charbonnel B
    Diabete Metab; 1993; 19(4):387-90. PubMed ID: 8293865
    [No Abstract]   [Full Text] [Related]  

  • 9. Practical aspects of hormone replacement therapy.
    Thorneycroft IH
    Prog Cardiovasc Dis; 1995; 38(3):243-54. PubMed ID: 7494885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin replacement in the menopause: effects on the endometrium and serum lipids.
    Williams DB; Moley KH
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transvaginal color Doppler assessment of endometrial status in normal postmenopausal women: the effect of hormone replacement therapy.
    Bonilla-Musoles F; Ballester MJ; Martí MC; Raga F; Osborne NG
    J Ultrasound Med; 1995 Jul; 14(7):503-7. PubMed ID: 7563297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and the menopause. Australian Menopause Society.
    MacLennan AH
    Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437
    [No Abstract]   [Full Text] [Related]  

  • 13. [Estrogens and progestins in hormone replacement therapy in menopause].
    La Vecchia C
    Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing safety and efficacy focus on endometrial protection.
    Boroditsky RS
    J Reprod Med; 2000 Mar; 45(3 Suppl):273-84. PubMed ID: 10756508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of endometrial carcinoma in postmenopause].
    Escudero Fernández M
    Rev Med Univ Navarra; 1993; 38(3):9-12. PubMed ID: 8134756
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical use of progestins in the menopausal patient: dosage and duration.
    Gambrell RD
    J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen.
    de Lignieres B
    J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
    Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
    Sturdee DW
    Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.